Cambridge Healthtech Institute’s 11th Annual
Optimizing Cell Culture Technology
Enhancing Knowledge for Growing Cells
August 3-4, 2015
Part of CHI's 7th Annual The Bioprocessing Summit
August 3-7, 2015 | Westin Copley Place Hotel | Boston, Massachusetts
This leading cell culture meeting explores today’s evolving strategies and technologies for improving mammalian cell cultivation, including omics technologies and Synthetic Biology. Industry experts offer insights into optimizing conditions, as well as, cell biology in an effort to improve yield, while also addressing where cell culture is heading as it meets ever greater production demands and quality standards.
The agenda again features a session focused on CHO (Chinese Hamster Ovary cells), as well as small-group breakout discussions that provide the opportunity to discuss important topics with your peers from around the world.
OPENING KEYNOTE PRESENTATION:
Getting to the Root of the Problem: What are the Fundamental Factors Limiting Growth and Productivity In CHO Cell Cultures?
Gregory Hiller, Ph.D., Associate Research Fellow, Culture Process Development, BioProcess R&D, Pfizer, Inc.
Development and Manufacturability Assessment of Chemically-Defined Medium for the Production of Protein Therapeutics in CHO Cells
Wai Lam W. Ling, Ph.D., Process Development & Engineering, Biologics BioProcess Development, Merck Research Labs
Host Cell Protein Expression during Extended CHO Cell Culture
Kristin Valente, Ph.D., Associate Principal Scientist, Merck
Tiffany Rau, Ph.D., Global Technical and Technology Manager, Eli Lilly and Company
Novel Virus-Like Particle and Nanoparticle Vaccine Production – An Overview of Cell Culture Process Development
Payal Biswas, PhD, Scientist, Upstream Process Development, Vaccine Production Program, Vaccine Research Center/NIAID/NIH
Enhanced Process Consistency, Robustness and Success in Cell Line Selection Using High-Throughput Bioreactors
Wenqi Xie, Associate Scientist II, Cell Culture Development, Biogen Idec
Biologics Data Platform for Tailored Support of Cell Line Development
Christian Bender, Ph.D., Computational Biologist, Global Drug Discovery, Global Biologics, Bayer HealthCare
Prediction of Cell Culture Performance and Molecule Quality Attributes from Micro-Scale Fed-Batch Cultures
Matthieu Stettler, Ph.D., Manager, Biotech Process Sciences – Biosimilars, Global Manufacturing & Supply, Merck Serono
Comparing Antibody Production Using Both Fed-Batch and Perfusion Methods
Daryl Powers, Ph.D., Senior Scientist, Early Cell Culture Development, Sanofi Global Biotherapeutics
Scale-Down Tools for Evaluation of Perfusion Cultivations
Martin Heitmann, Ph.D., Senior Scientist, Cell Culture Technology, Novo Nordisk A/S
Optimizing Osmolality and Cell Expansion Strategy to Improve Cell Culture Performance in a Perfusion-Based Bioreactor Process
Christopher Rives, Ph.D., Senior Upstream Development Engineer, BioProcess Development, Shire Plc
Portable X-ray Fluorescence Spectrometer: A Tool For Biopharmaceutical Forensic Investigations
Jessica Mondia, Ph.D., Research Scientist, Biogen Idec, Inc.
For more details on the conference, please contact:
Senior Conference Director
For exhibit & sponsorship opportunities, please contact: